Skip to main contentSkip to navigation
Sirius Investors
Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc.

NBIX
NASDAQHealthcare

NBIX Financial Statements & Analysis

Complete financial statements for NBIX including income statement, balance sheet, and cash flow statement. Analyze NBIX's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).

Financial Health Score

Financial Health Score

/100
Unlock score for free

Already registered? Sign in

Income Statement

Revenue
8.5%
Net Income
39.7%
Gross Margin
-0.0%
Operating Margin
16.4%

Balance Sheet

Current Ratio
-13.7%
Debt to Equity
-6.6%
Asset Turnover
2.4%

Cash Flow

Operating Cash Flow
10.3%
Net Cash Flow
-84.9%
Free Cash Flow
11.0%
Cash Flow to Debt
12.8%

Income Statement Comparison

Revenue & Net Income

Period Comparison

MetricTTM Q4 '25TTM Q1 '26ChangeImpact
Revenue2.86B3.10B8.5%
Gross Profit2.81B3.05B8.4%
Operating Income619.10M781.50M26.2%
Net Income478.60M668.60M39.7%
EPS1.201.6839.4%
EBITDA733.00M955.80M30.4%
Gross Margin98.18%98.17%0.0%
Operating Margin21.64%25.19%16.4%
Net Income Margin16.73%21.55%28.8%
R&D Expenses1.02B1.05B3.2%

Income Statement Full Table

Free users can view the last 3 periods. Upgrade to see the full history.

Upgrade
MetricTTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Revenue3.10B2.86B2.68B
Gross Profit3.05B2.81B2.64B
Operating Income781.50M619.10M550.20M
Net Income668.60M478.60M428.00M
EPS1.681.201.08
EBITDA955.80M733.00M679.30M
Gross Margin98.17%98.18%98.37%
Operating Margin25.19%21.64%20.51%
Net Income Margin21.55%16.73%15.95%
R&D Expenses1.05B1.02B943.10M

Our detailed financial analysis helps investors understand NBIX's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track NBIX's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.

Financial Metrics

Want to dive deeper into NBIX's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.

View Financial Metrics
Neurocrine Biosciences, Inc. (NBIX) Financial Statements (2026): Income, Balance Sheet & Cash Flow | Sirius Investors